UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-A

 

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF l934

 

 

 

Profound Medical Corp.

(Exact name of Registrant as specified in its charter)

 

 

 

Ontario, Canada   NOT APPLICABLE
(State of incorporation or organization)   (I.R.S. Employer Identification No.)

 

2400 Skymark Avenue, Unit 6, Mississauga, Ontario   L4W 5K5
(Address of principal executive offices)   (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered 

 

Name of each exchange on which

each class is to be registered 

Common Shares   The Nasdaq Stock Market LLC

 

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ¨

 

Securities Act registration statement file number to which this form relates: 333-233997

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

None

(Title of Class)

 

 

 

 

  

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The securities to be registered consist of common shares, no par value (“Common Shares”) of Profound Medical Corp. (the “Registrant”). The description of the Registrant’s Common Shares under the section captioned “Description of Securities” in the prospectus included in the Registrant’s registration statement on Form F-10 (File No. 333-233997) (the “Registration Statement”), initially filed with the Securities and Exchange Commission on September 27, 2019, as subsequently amended by any amendments to such Registration Statement, is incorporated herein by reference.

 

Item 2. Exhibits.

 

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized, in the City of Mississauga, Province of Ontario, Canada on October 18, 2019.

 

  PROFOUND MEDICAL CORP.
     
  By:   /s/ Aaron Davidson
     

Name: Aaron Davidson

Title: Chief Financial Officer